As Ruger has just explained
Also from the AGM presentation;
Mr. Huang Ping, Vice Chairman of Shenghe Resources Holding Co, Ltd said
"We continue to believe that the Ngualla Project is the premier undeveloped rare earth project in the world. This Term Sheet demonstrates our commitment to work with Peak and Mamba Minerals to further optimise the Ngualla Project and to expedite its development and funding"
Shenghe partnership … key elements
Offtake
Binding offtake agreement in place
Funding
Full project funding solution via Shenghe’s A$96m
investment into NGUK as well as project-level debt facility
Project construction and development
Shenghe to participate in tender for project EPCM, EPC or EPS
execution package
Technical collaboration
Ongoing optimisation of current flow sheet as well as
collaboration around in-country downstream development
Peak and Shenghe … a transformational partnership
Binding offtake in combination with a non-binding investment, development and
funding Term Sheet with Shenghe underpins an integrated development solution
Shenghe to invest A$96m to subscribe for a 50% stake in Ngualla Group UK Ltd
Implied valuation of A$0.36/share on a post-transaction basis
Full project funding solution No requirement for Peak to contribute any additional development equity funding
Satisfaction of conditions precedent and financial close of Shenghe transaction Q1, 2025
Final Investment Decision Q1, 2025
In summary;
- Final investment decision before the end of March
- Free carried from here. No requirement for any additional development funding from Peak
- The premier undeveloped rare earth project in the world
- Shenghe is unwavering with serious intent!
and as Ed Dowd would say, "you can take that to the bank!"
- Forums
- ASX - By Stock
- PEK
- Ann: Completion of Capital Raising
PEK
peak rare earths limited
Add to My Watchlist
1.79%
!
27.5¢

Ann: Completion of Capital Raising, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $96.83M |
Open | High | Low | Value | Volume |
28.0¢ | 28.5¢ | 27.5¢ | $295.2K | 1.052M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 379024 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 91331 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 379024 | 0.275 |
5 | 413778 | 0.270 |
6 | 369000 | 0.265 |
7 | 1526383 | 0.260 |
4 | 333999 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 91331 | 6 |
0.285 | 315500 | 5 |
0.290 | 1866 | 1 |
0.300 | 153029 | 3 |
0.305 | 40000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online